A detailed history of Central Pacific Bank Trust Division transactions in Amgen Inc stock. As of the latest transaction made, Central Pacific Bank Trust Division holds 1,464 shares of AMGN stock, worth $457,426. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,464
Holding current value
$457,426
% of portfolio
0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$268.87 - $324.56 $393,625 - $475,155
1,464 New
1,464 $414 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $167B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Central Pacific Bank Trust Division Portfolio

Follow Central Pacific Bank Trust Division and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Pacific Bank Trust Division, based on Form 13F filings with the SEC.

News

Stay updated on Central Pacific Bank Trust Division with notifications on news.